STX17 Protein

STX17 Protein — Syntaxin 17

Introduction

STX17 (Syntaxin 17) is a SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein that plays a critical role in autophagosome-lysosome fusion and mitophagy. As a member of the syntaxin family of SNARE proteins, STX17 mediates the docking and fusion of autophagosomes with lysosomes, a crucial step in the [autophagy](/entities/autophagy)-lysosomal degradation pathway. This function is particularly important for neuronal health, as [neurons](/entities/neurons) are highly dependent on autophagy for protein quality control and organelle turnover. Dysregulated STX17 function has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease. [@itakura2012]

STX17 Protein — Syntaxin 17

Introduction

STX17 (Syntaxin 17) is a SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein that plays a critical role in autophagosome-lysosome fusion and mitophagy. As a member of the syntaxin family of SNARE proteins, STX17 mediates the docking and fusion of autophagosomes with lysosomes, a crucial step in the [autophagy](/entities/autophagy)-lysosomal degradation pathway. This function is particularly important for neuronal health, as [neurons](/entities/neurons) are highly dependent on autophagy for protein quality control and organelle turnover. Dysregulated STX17 function has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease. [@itakura2012]

<div class="infobox infobox-protein"> [@diao2015]
<table> [@hubbard2019]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">STX17 Protein</th></tr> [@ganley2019]
<tr><td><strong>Protein Name</strong></td><td>Syntaxin 17</td></tr> [@nixon2017]
<tr><td><strong>Gene</strong></td><td>[STX17](/genes/stx17)</td></tr> [@mizushima2011]
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9NYQ6" target="_blank">Q9NYQ6</a></td></tr> [@yamamoto2018]
<tr><td><strong>Alternative Names</strong></td><td>STX17, Syntaxin-17</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>28 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>242 amino acids</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Autophagosomes, Lysosomes, Endoplasmic Reticulum</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Syntaxin family, SNARE proteins</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/bacterial-infection" style="color:#ef9a9a">Bacterial Infection</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-5e68b4ad" style="color:#ce93d8" title="Score: 0.47">Autophagosome Maturation Checkpoint Cont...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">754 edges</a></td>
</tr>
</table>
</div>

Overview

STX17 is a unique syntaxin that localizes to the autophagosome and is essential for autophagosome-lysosome fusion [1](https://doi.org/10.1083/jcb.201403039). Unlike most SNARE proteins that are localized to specific organelles, STX17 is recruited to completed autophagosomes, where it forms a SNARE complex with SNAP29 and VAMP8 to mediate fusion with lysosomes [2](https://doi.org/10.1083/jcb.201602014). This function makes STX17 a central player in the final step of autophagy.

STX17 is particularly important for selective autophagy pathways, including mitophagy (selective degradation of mitochondria), pexophagy (selective degradation of peroxisomes), and aggrephagy (selective degradation of protein aggregates). In neurons, where autophagy is essential for synaptic maintenance and axonal homeostasis, STX17 function is critical for preventing the accumulation of damaged organelles and protein aggregates that drive neurodegeneration [3](https://doi.org/10.1016/j.tcb.2019.04.008).

Structure

STX17 has a distinct domain architecture optimized for its role in autophagy:

• N-terminal regulatory domain: Contains an N-terminal regulatory region that autoinhibits SNARE activity
• SNARE domain: The central SNARE motif that forms the four-helix bundle with SNAP29 and VAMP8
• Transmembrane anchor: C-terminal transmembrane domain that anchors STX17 to autophagosomal membranes
• LC3-interacting region (LIR): Contains a LIR motif that allows binding to LC3/ATG8 on autophagosomes

Normal Function

Autophagosome-Lysosome Fusion

STX17 orchestrates the final step of autophagy:

Mitophagy

STX17 is essential for mitophagy:

• PINK1/Parkin pathway: Damaged mitochondria are tagged with ubiquitin for autophagic clearance
• OPTN/NDP52 receptors: Autophagy receptors recruit autophagosomes to damaged mitochondria
• STX17 recruitment: STX17 is recruited to mitochondria-containing autophagosomes
• Lysosomal fusion: Fusion with lysosomes completes mitophagy

Neuronal Autophagy

In neurons, STX17 supports:

• Synaptic maintenance: Autophagy removes damaged synaptic proteins
• Axonal homeostasis: Autophagy prevents axonal swellings and degeneration
• Protein quality control: Aggregate clearance maintains proteostasis
• Organelle turnover: Damaged mitochondria and ER are removed

Role in Neurodegenerative Diseases

Alzheimer's Disease

STX17 dysfunction contributes to AD pathogenesis:

• [Amyloid-beta](/proteins/amyloid-beta) accumulation: Impaired autophagic-lysosomal pathway leads to Aβ accumulation
• [Tau](/proteins/tau) pathology: Autophagy defects contribute to tau aggregation
• Lysosomal dysfunction: STX17 dysfunction exacerbates lysosomal impairment
• Neuronal vulnerability: Autophagy is essential for neuron survival

Parkinson's Disease

STX17 plays critical roles in PD:

• [Alpha-synuclein](/proteins/alpha-synuclein) clearance: Autophagy clears α-synuclein aggregates
• Mitophagy: PINK1/Parkin-mediated mitophagy requires STX17
• LRRK2 pathogenesis: LRRK2 mutations affect autophagy
• Dopaminergic neuron vulnerability: Autophagy is crucial for dopaminergic neurons

Huntington's Disease

STX17 dysfunction contributes to HD:

• [Huntingtin](/proteins/huntingtin) aggregation: Autophagy clears mutant huntingtin
• Transcriptional dysregulation: Autophagy affects transcriptional regulator turnover
• Mitochondrial dysfunction: Mitophagy impairment leads to energy deficits

Amyotrophic Lateral Sclerosis (ALS)

STX17 may play a role in ALS:

• Protein aggregate clearance: Autophagy removes [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregates
• Axonal transport: Autophagy supports axonal maintenance
• Motor neuron vulnerability: Motor neurons are particularly dependent on autophagy

Therapeutic Implications

STX17 represents a therapeutic target:

Biomarker Applications

STX17 levels serve as biomarkers:

• Autophagy flux: STX17 indicates autophagic activity
• Disease progression: STX17 dysfunction correlates with severity
• Therapeutic response: Autophagy modulation indicates treatment efficacy

Interacting Partners

STX17 interacts with key autophagy proteins:

• SNAP29: Lysosomal SNARE that forms the SNARE complex
• VAMP8: Lysosomal v-SNARE for fusion
• LC3/ATG8: Autophagosomal protein that recruits STX17
• ATG14L: Regulates STX17 recruitment to autophagosomes
• Pacer: Regulator of STX17-mediated fusion

Pathway & Interaction Diagram

Interactive diagram showing STX17's key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• [STX17 Gene](/genes/stx17)
• [SNARE Proteins](/mechanisms/snare-proteins)
• [Autophagy](/mechanisms/autophagy)
• [Mitophagy](/mechanisms/mitophagy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntington-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)

Background

The study of Stx17 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Autophagosome Maturation Checkpoint Control](/hypothesis/h-5e68b4ad) — <span style="color:#ffd54f;font-weight:600">0.47</span> · Target: STX17